Health Science Chief Medical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article
Share this article
CAMBRIDGE, Mass., Jan. 26, 2021 /PRNewswire/  Senda Biosciences, a therapeutics platform company creating novel categories of medicines based on a new field of science called Intersystems Biology, announced today that it has entered into a strategic collaboration with Nestlé Health Science for the development of novel nutritional therapies for a wide range of metabolic conditions, including obesity and glycemia. 
The companies will focus initially on accelerating first-in-human clinical studies on up to three small molecule compounds developed by Senda, leveraging the capabilities of Nestlé Health Science, a global leader in the science of nutrition. The compounds have been rationally designed based on Senda s Intersystems Biology discovery platform, and screened through Senda s proprietary bioassays for their potential to improve metabolic health. In preclinical studies these compounds have shown the ability to achieve susta ....

United Kingdom , Hans Juergen Woerle , Guillaume Pfefer , Senda Biosciences , Health Science , Health Science Nhsc , Intersystems Biology , Health Science Chief Medical , Scientific Officer Hans Juergen , ஒன்றுபட்டது கிஂக்டம் , அனுப்புதல் உயிர் அறிவியல் , ஆரோக்கியம் அறிவியல் , ஆரோக்கியம் அறிவியல் தலைமை மருத்துவ , அறிவியல் அதிகாரி ஹான்ஸ் ஜூர்கன் ,